In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
Amira Abdelrasoul, PhD, PEng, is an associate professor in the Department of Chemical and Biological Engineering and the Division of Biomedical Engineering at the University of Saskatchewan. She…
Chronic kidney disease often goes unnoticed until it reaches an advanced stage. Early detection can help treat and prevent the disease before it necessitates dialysis or kidney transplantation.…
Sheeram Akilesh, MD, PhD, discusses spatial transcriptomics and its application in studying kidney disease. He explains the concept of spatial transcriptomics, which involves deeply interrogating a tissue section…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses the management of chronic kidney disease. She explains that medications are prescribed to treat risk factors that can speed up…
Terry J. Watnick, MD, professor of neurology and director of Maryland PKD Clinical Center of Excellence, explains that polycystic kidney disease (PKD) is a genetic disorder that causes…
Dinushika Mohottige, MD, a general nephrologist and assistant professor at the ICAHN School of Medicine at Mount Sinai, discusses the causes, symptoms, and treatments of kidney disease. The…
Nephrologist Sumeska Thavarajah, MD, of Johns Hopkins, discusses treatment options for end-stage kidney disease, also known as end-stage renal disease. The treatments include dialysis, transplantation, or medical management,…
Brian Shuch, MD, director of the UCLA Kidney Cancer Program, explains what to expect after a radical nephrectomy. The procedure can be done minimally invasively, either laparoscopically or robotically,…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
April W. Armstrong, MD, MPH, of @KeckMedUSC, and Erin E. Boh, MD, PhD, of @TulaneMedicine, discuss the use of IL-23 and IL-17 inhibitors in #psoriaticdisease.
